Hypothesis

Locus coeruleus (LC) neurons resist age‑related calbindin‑D28k loss because they constitutively activate store‑operated calcium entry (SOCE) via STIM1/Orai1, which buffers cytosolic Ca2+ independently of endogenous calcium‑binding proteins. In basal forebrain cholinergic neurons (BFCN) this compensatory pathway is silenced with aging, leaving them vulnerable to calcium‑induced excitotoxicity, mitochondrial stress and neurofibrillary tangle formation.

Mechanistic Basis

Aging reduces calbindin and parvalbumin in BFCN, elevating resting [Ca2+]i and promoting MCU overload, ROS production and tau phosphorylation [1][2]. LC neurons, however, maintain stable calbindin expression [2] and show higher basal STIM1 puncta formation, indicating persistent ER‑Ca2+ sensing. We propose that LC neurons rely on SOCE to extrude excess Ca2+ through plasma‑membrane Orai1 channels while simultaneously loading mitochondria via the Na+/Ca2+ exchanger (NCLX), thereby keeping mitochondrial Ca2+ within a safe range. When SOCE is inhibited, LC neurons exhibit the same calcium dysregulation profile as BFCN, leading to increased susceptibility to tangle pathology.

Testable Predictions

1. In aged primate BFCN, STIM1 and Orai1 mRNA and protein levels will be significantly lower than in young animals, whereas LC will show no age‑dependent decline.
2. Pharmacological block of SOCE (e.g., with GSK‑7975A) in young LC neurons will reproduce the calcium overload, mitochondrial ROS and early tau phosphorylation seen in aged BFCN.
3. AAV‑mediated overexpression of STIM1/Orai1 in aged BFCN will restore cytosolic Ca2+ buffering, reduce mitochondrial Ca2+ overload, decrease ROS, and prevent neurofibrillary tangle formation despite low calbindin.
4. Conditional knockout of STIM1 in LC neurons of adult mice will precipitate calbindin‑independent calcium dysregulation and accelerate tau pathology in models of Alzheimer’s disease.

Potential Experimental Approaches

• Perform quantitative immunoblotting and RNAscope for STIM1, Orai1, calbindin and parvalbumin in microdissected BFCN and LC from young, aged and Alzheimer’s disease human post‑mortem tissue (samples from [2][3]).
• Use primary cultures of BFCN and LC derived from embryonic rat or human iPSC‑neurons; treat with thapsigargin to deplete ER stores and measure SOCE influx with Fura‑2 AM; assess mitochondrial Ca2+ with Rhod‑2 AM and ROS with MitoSOX.
• Deliver AAV9‑STIM1‑IRES‑Orai1 or AAV9‑Calb1 to aged rats; evaluate cognition (Morris water maze), calcium imaging in vivo via two‑photon microscopy, and tangle burden (AT8 immunohistochemistry) [5].
• Generate LC‑specific Stim1 floxed mice crossed with Dbh‑CreERT2; induce recombination in adulthood and monitor tau pathology using the PS19 model.

If SOCE compensates for calbindin loss in LC, then enhancing this pathway in vulnerable BFCN should mimic the LC protective phenotype, offering a therapeutic avenue that bypasses the need to restore calcium‑binding proteins directly.